Vaccinating transplant recipients

Nature Medicine

Volumn 11, Issue 11, 2005, Pages 1162-1163

  Molldrem, Jeffrey J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

CANCER CHEMOTHERAPY; CANCER PREVENTION; DRUG EFFECT; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNIZATION; LYMPHOMA; MYELOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; VACCINATION;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, NATURAL; IMMUNOTHERAPY; PNEUMOCOCCAL VACCINES; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VACCINATION;

EID: 30744473195     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1105-1162     Document Type: Short Survey

References (9)

1. Rapoport, A.P. et al. Nat. Med. 11, 1230-1237 (2005)
2. Storek, J. et al. Blood 101, 3319-3324 (2003).
3. Fry, T.J. & Mackall, C.L. Bone Marrow Transplant. 35 Suppl 1, S53-S57 (2005).
4. Goldrath, A.W. & Sevan, M.J. Immunity 11, 183-190 (1999).
5. Liebowitz, D.N., Lee, K.P. & June, C.H. Curr. Opin. Oncol. 10, 533-541 (1998).
6. Molldrem, J.J. et al. J. Clin. Invest. 111, 639-647 (2003).
7. Fry, T.J. et al. Blood 97, 1525-1533 (2001).
8. Mackall, C.L., Hakim, F.T. & Gress, R.E. Immunol. Today 18, 245-251 (1997).
9. Watanabe, N. et al. Nat. Immunol. 5, 426-434 (2004).